Trial intelligence / Profile preview

InsuBiomm R versus Humulin R PK/PD clamp study in adults with type 1 diabetes

RBR-7mvgfcPhase 1Not yet recruiting

Sponsor
ICF
Start
Jul 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by ICF. Primary endpoints: Pharmacokinetics of regular human insulin and Pharmacodynamics of regular human insulin. Planned start Jul 2018; status: not yet recruiting.

02

Drugs

human insulin
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on RBR-7mvgfc.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-7mvgfc.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call